Cambridge, MA, United States of America

Alexander V Kelin

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Alexander V. Kelin

Introduction

Alexander V. Kelin is an accomplished inventor based in Cambridge, MA, USA. With a remarkable portfolio of five patents, he has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-ligand conjugates. His innovative work has the potential to transform the delivery of therapeutic agents in medicine.

Latest Patents

Among his latest patents is the invention titled "Oligonucleotide-ligand conjugates and process for their preparation". This invention focuses on ligand conjugates of oligonucleotides, specifically targeting iRNA agents such as siRNA. The ligands are primarily derived from monosaccharides, enhancing the efficacy of in vivo delivery systems for oligonucleotides. This groundbreaking work is poised to advance the therapeutic use of RNA-based treatments.

Career Highlights

Alexander currently works at Alnylam Pharmaceuticals, Inc., a leading company in RNA interference technology. His role involves innovative research that lies at the cutting edge of medical biotechnology. His contributions have not only expanded the potential applications of oligonucleotides but have also set a precedent for future developments in this area.

Collaborations

Throughout his career, Alexander has collaborated with notable scientists and researchers, including Muthiah Manoharan and Kallanthottathil G. Rajeev. These partnerships have allowed for a rich exchange of ideas and expertise, leading to advancements in their collective work and shared vision of improving healthcare through innovation.

Conclusion

In summary, Alexander V. Kelin exemplifies the spirit of innovation through his contributions to biotechnology and his focus on the development of oligonucleotide-ligand conjugates. His work at Alnylam Pharmaceuticals, Inc. and collaborations with fellow researchers highlight the importance of teamwork and creativity in achieving groundbreaking scientific advancements. As the field of biotechnology continues to evolve, inventors like Alexander will play a crucial role in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…